Immune proteins called HLA molecules help to activate killer T cell responses against pathogens. But according to a study that will be published online on December 14th in the Journal of Experimental Medicine, one particular group of HLA molecules cripples this activation, perhaps explaining why HIV-infected individuals who express these HLAs progress to AIDS more rapidly than others.
AIDS develops more rapidly in individuals who express HLA B*35-Px than in those who express the highly related HLA B*35PY proteins. The new study, lead by Xu Yu at Massachusetts General Hospital, shows that B*35-Px molecules bind to and activate an inhibitory receptor on dendritic cells—cells that are needed to activate protective T cells. These findings suggest that inhibitory dendritic cell receptors should be taken into consideration during future efforts to design HIV-1 vaccines and therapies.
More information: Huang, J., et al. 2009. J. Exp. Med. doi:10.1084/jem.20091386
Source: Rockefeller University (news : web)
Explore further: HIV antibodies block infection by reservoir-derived virus in laboratory study